These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9143397)

  • 21. The human leukocyte antigen class I genes in nasopharyngeal carcinoma risk.
    Hassen E; Nahla G; Bouaouina N; Chouchane L
    Mol Biol Rep; 2010 Jan; 37(1):119-26. PubMed ID: 19449168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of human leukocyte antigen-A (HLA-A), other non-HLA markers on chromosome 6p21 and risk of nasopharyngeal carcinoma.
    Hsu WL; Tse KP; Liang S; Chien YC; Su WH; Yu KJ; Cheng YJ; Tsang NM; Hsu MM; Chang KP; Chen IH; Chen TI; Yang CS; Goldstein AM; Chen CJ; Chang YS; Hildesheim A
    PLoS One; 2012; 7(8):e42767. PubMed ID: 22880099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nasopharyngeal carcinoma as a paradigm of cancer genetics.
    Simons MJ
    Chin J Cancer; 2011 Feb; 30(2):79-84. PubMed ID: 21272439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological analysis of human leukocyte antigens-A and -B antigens in Thai patients with nasopharyngeal carcinoma.
    Pimtanothai N; Kangwanshiratada O; Charoenwongse P
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S237-41. PubMed ID: 12929995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fine-mapping of HLA class I and class II genes identified two independent novel variants associated with nasopharyngeal carcinoma susceptibility.
    Wang TM; Zhou T; He YQ; Xue WQ; Zhang JB; Zheng XH; Li XZ; Zhang SD; Zeng YX; Jia WH
    Cancer Med; 2018 Dec; 7(12):6308-6316. PubMed ID: 30378292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin allotypes in patients with nasopharyngeal carcinoma.
    Chaabani H; Ellouz R
    Hum Hered; 1986; 36(6):402-4. PubMed ID: 3793120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States.
    Burt RD; Vaughan TL; McKnight B; Davis S; Beckmann AM; Smith AG; Nisperos B; Swanson GM; Berwick M
    Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):879-87. PubMed ID: 8922295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between nasopharyngeal carcinoma and HLA antigens in Greeks.
    Zervas J; Gregoriadis S; Tourlas D; Varlegidis E; Pantazopoulos P
    Panminerva Med; 1983; 25(4):255-7. PubMed ID: 6584851
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic susceptibility to nasopharyngeal carcinoma within the HLA-A locus in Taiwanese.
    Lu CC; Chen JC; Jin YT; Yang HB; Chan SH; Tsai ST
    Int J Cancer; 2003 Mar; 103(6):745-51. PubMed ID: 12516093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta 2-microglobulin and HLA-DR expression in relation to the presence of Epstein-Barr virus in nasopharyngeal carcinomas.
    Kouvidou C; Rontogianni D; Tzardi M; Datseris G; Panayiotides I; Darivianaki K; Karidi E; Delides G; Kanavaros P
    Pathobiology; 1995; 63(6):320-7. PubMed ID: 8738471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of HLA-B alleles in nasopharyngeal carcinoma patients and normal controls in Thailand.
    Pimtanothai N; Charoenwongse P; Mutirangura A; Hurley CK
    Tissue Antigens; 2002 Mar; 59(3):223-5. PubMed ID: 12074714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenetic aspects of nasopharyngeal carcinoma. IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related HLA profile (A2, Singapore 2).
    Simons MJ; Wee GB; Goh EH; Chan SH; Shanmugaratnam K; Day NE; de-Thé G
    J Natl Cancer Inst; 1976 Nov; 57(5):977-80. PubMed ID: 1003552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer.
    Gamzatova Z; Villabona L; van der Zanden H; Haasnoot GW; Andersson E; Kiessling R; Seliger B; Kanter L; Dalianis T; Bergfeldt K; Masucci GV
    Tissue Antigens; 2007 Sep; 70(3):205-13. PubMed ID: 17661908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenetics of nasopharyngeal carcinoma--position in 1980.
    Chan SH
    Ann Acad Med Singap; 1980 Jul; 9(3):296-9. PubMed ID: 7212610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histocompatibility leukocyte antigen patterns and nasopharyngeal carcinoma.
    Simons MJ; Day NE
    Natl Cancer Inst Monogr; 1977 Dec; 47():143-6. PubMed ID: 613232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Association study of chromosome 4 STRs polymorphisms with nasopharyngeal carcinoma].
    Guo XC; O'Brien SJ; Winkler C; Scott K; Hutcheson H; David V; Kessing B; Zheng YM; Liao J; Lui Y; Guy de T; Zeng Y
    Yi Chuan; 2006 Jul; 28(7):783-90. PubMed ID: 16825163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunogenetics of nasopharyngeal carcinoma].
    Chaaben AB; Abaza H; Douik H; Harzallah L; Charron D; Krishnamoorthy R; Guemira F; Tamouza R
    Ann Biol Clin (Paris); 2014; 72(3):281-91. PubMed ID: 24876139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis.
    Goldsmith DB; West TM; Morton R
    Clin Otolaryngol Allied Sci; 2002 Feb; 27(1):61-7. PubMed ID: 11903375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic fixity in the human major histocompatibility complex and block size diversity in the class I region including HLA-E.
    Romero V; Larsen CE; Duke-Cohan JS; Fox EA; Romero T; Clavijo OP; Fici DA; Husain Z; Almeciga I; Alford DR; Awdeh ZL; Zuñiga J; El-Dahdah L; Alper CA; Yunis EJ
    BMC Genet; 2007 Apr; 8():14. PubMed ID: 17430593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells.
    Khanna R; Busson P; Burrows SR; Raffoux C; Moss DJ; Nicholls JM; Cooper L
    Cancer Res; 1998 Jan; 58(2):310-4. PubMed ID: 9443410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.